Navigation Links
Researchers identify cell group key to Lyme disease arthritis
Date:12/3/2008

SAN DIEGO (December 3, 2008) A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease.

"Our findings are that the NK T cells are critical to preventing the chronic inflammatory infection that causes Lyme arthritis and they participate in clearing the bacteria which cause it," said Mitchell Kronenberg, Ph.D., the La Jolla Institute's president & scientific director and co-senior author on the study, which used a mouse model of Lyme disease. Lyme disease is caused by Borrelia burgdorferi, a bacterium transmitted to humans by the bite of infected deer ticks. Typical symptoms include fever, headache, fatigue, and sometimes skin rashes. If left untreated, it can spread to the joints, the heart and the nervous system, and it can lead to serious health problems. Lyme disease currently is the most common vector (insect)-borne disease in the United States.

"What this study demonstrates is that NK T cells are an important part of our defense against Lyme disease," said Timothy J. Sellati, Ph.D., an associate professor at Albany Medical College and co-senior author on the study. "This offers the possibility that we can exploit that knowledge therapeutically and potentially develop immunological agents that can trigger more NK T cells to aide in fighting this disease." Sellati added that "NK T cells alone cannot clear Lyme disease, but are a key part of a collective immune defense."

The study's findings are outlined in a paper, "NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi," published this week in the online version of the journal Proceedings of the National Academy of Sciences.

In an earlier study published in Nature Immunology, Kronenberg, Sellati and co-workers had shown that a glycolipid, a type of fat, found in the membrane of Borrelia burgdorferi triggered an immune response from the NK T cells. "We had found that if you gave that lipid to mice or humans, it would activate NK T cells," Kronenberg said. While this suggested the cells might play a significant role in Lyme disease, "we were missing in vivo (in the body) evidence showing that the NK T cells were activated following infection and were important for killing and clearing the Lyme disease bacteria," he said, noting that the latest study demonstrates this in an animal model.

Sellati said the finding is particularly important because it opens new lines of investigation as to the causes of chronic Lyme disease. "That's what's so exciting when you identify a new cell type as playing a central role in preventing the disease process," he said. "So in those individuals who have a more severe form of the disease, you can study their NK T cells and see if there's some deficiency that prevents those NK T cells from killing and clearing the bacteria."

In their studies, the researchers worked to model the natural route of Lyme disease infection as closely as possible. "The way people typically get Lyme disease is that they're out hiking and they get bitten by a deer tick," said Kronenberg. "So what we did in the lab was to get ticks infected with Borrelia burgdorferi from collaborators at the University of Connecticut Health Science Center and then used those ticks to infect mice in a confined and controlled environment."

The researchers used one group of mice genetically engineered not to have NK T cells, while the control group had the cells. "The mice that didn't have NK T cells were not as capable of clearing the (Lyme disease) bacteria," Kronenberg said. "And they developed a chronic arthritis, while the control mice did not." He said the results were quite marked. "You could see under the microscope more numerous inflammatory cells in the joints of the mice that lacked the NK T cells weeks after infection."

Discovered in the 1990s, NK T cells are disease-fighting white blood cells of the immune system whose inner workings are still being defined. While most T cells respond to foreign proteins to protect the body, NK T cells are unique in that they respond to glycolipids, which are natural biochemicals made of linked fat and sugar. Prized for initiating a fast and vigorous immune response, NK T cells are emerging as a subject of significant scientific interest because of their potential for fighting bacterial infections and cancer. Kronenberg and Sellati have been among the nation's leaders in studying these cells.

Kronenberg's laboratory was among the first to identify bacteria which naturally induce an immune response from the NK T cells. Thus far, he has identified two such bacteria Borrelia burgdorferi and Sphingomonas species, a fairly benign bacteria found throughout the environment. However, he believes many other types of bacteria may also trigger the NK T cells. "This is an exciting possibility that needs to be further explored as it could lead to the development of treatments for many bacterial diseases."


'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Phynd Technologies, Inc. announced recently the signing of three ... and Shore Medical Center – Somers Point, NJ. The new clients range in bed ... the breadth of Phynd’s solution and its interoperability. , Houston Methodist is a leading ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview ... and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical insurance ... she calls the country’s “modern medical money maelstrom.” , During the interview with ...
(Date:5/31/2016)... ... ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree from ... where he graduated in the top ten percentile of his class. Dr. Ditta has ... has been a member in good standing for thirty years in the American Dental ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet ... to the healthcare industry, The University of Scranton is adding a Certificate in ... to a career in rapidly growing field of healthcare information. , Healthcare ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Super Powder, a ... to on the go individuals and dedicated athletes, continues to transform the nutritional supplement ... with whey, pea and milk protein, branched-chain amino acids (BCAA), alkaline minerals, wheat grass, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: